59 results on '"RIZZELLO, F."'
Search Results
2. P414 Timing of biologics discontinuation is not associated with postoperative complications (POCs), infective complications, bleeding, or intra-abdominal septic complications (IASCs) after primary ileocecal resection for Crohn’s Disease: a retrospective analysis of 237 patients in a tertiary centre
3. P233 Cytomegalovirus colitis in patients with moderate-to-severe Ulcerative Colitis: diagnosis, clinical impact and treatment efficacy
4. P214 Effects of rectal stump proctitis on short-term postoperative complications after proctectomy and ileal pouch-anal anastomosis for Ulcerative Colitis
5. P706 Monitoring asymptomatic patients with Crohn's disease: the role of intestinal ultrasound
6. P216 Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocecal resection for Crohn’s disease: a retrospective analysis of 853 consecutive patients treated in a tertiary centre
7. P639 Percutaneous drainage vs surgery as definitive treatment for anastomotic leak after intestinal resection in patients with Crohn’s disease
8. P527 Telemedicine in IBD patients: results of a national survey of the Italian IBD patients’ association (AMICI Onlus)
9. P616 Safety of COVID-19 vaccines in patients with IBD
10. P420 Long term efficacy of ustekinumab in Crohn’s disease patients after vedolizumab failure
11. P199 Ileal pouch-anal anastomosis in women of childbearing age affected by ulcerative colitis: a single-centre study on the risk factors for infertility and outcomes of pregnancy over 17 years
12. DOP33 Predictors of ileo-rectal anastomosis, permanent ileostomy and recurrence of disease after total colectomy for Crohn’s Colitis: Results over 20 years
13. P417 Long-term deep remission after adalimumab discontinuation in Crohn’s disease patients
14. P568 Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn’s disease
15. P463 COVID-19 vaccination willingness and hesitancy in patients with Inflammatory Bowel Diseases (IBD): analysis of determinants in a national survey of the Italian IBD patients’ association (AMICI Onlus)
16. P443 Haemorrhoidal Artery Ligation – Recto-Anal Repair (HAL-RAR) with mucopexy for grade III hemorrhoids in IBD patients
17. P-02-62 Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)-Infected Men in Serodiscordant Couples: Impact on the Reproductive Outcomes
18. DOP62 Morbidity after primary ileocecal resection for Crohn’s disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre
19. P615 Safety of vedolizumab in the treatment of IBD in a single tertiary centre
20. P367 Real-life long-term effectiveness and treatment persistence of vedolizumab in a single tertiary care cohort of Crohn’s disease patients
21. P442 Strictureplasty for Crohn’s disease of the small bowel in the biological era: long-term outcomes and risk factors for site specific recurrence
22. P208 Impact of Pillcam Crohn's capsule on diagnostic yield and clinical management: results of the first multi-centre, observational study
23. P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era
24. P683 Maintenance of deep remission in patients with ulcerative colitis treated with thiopurines after withdrawal of the drug: Perspective real-life experience of a single centre
25. P269 A new dedicated capsule for diagnosis and monitoring of Crohn’s disease. First patient series
26. P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years
27. P574 Limitations and difficulties in using anti-TNF-alpha agents in inflammatory bowel disease. A survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)
28. P652 Unmet needs of physicians managing inflammatory bowel disease. A Survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)
29. DOP058 Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn's disease?
30. P571 Can Crohn's colits be cured by surgery?
31. P629 Epidemiological features and disease related concerns of a large cohort of Italian patients with active Crohn's disease
32. P452 Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program
33. P370 Prospective withdrawal trial of azathioprine (AZA) in ulcerative colitis (UC)
34. P604 Adalimumab for the treatment of post-operative recurrence of Crohn's disease. A single centre experience
35. P395 Re-induction regimen in Crohn's disease adalimumab failure or disease relapse after a first adalimumab course. A single centre experience
36. P391 Risk of short-term postoperative complications in patients treated with azathioprine for Crohn's disease. A single center experience
37. P377 Long-term outcome after infliximab treatment for distal refractory ulcerative colitis. A single tertiary center experience
38. P289 Concordance in IBD endoscopic scoring requires expertise and training: Preliminary results of an ongoing IG-IBD study
39. P393 Combination of surgical therapy and local injections of adalimumab in treatment of complex perianal Crohn's disease
40. P386 Long term functional results and quality of life after restorative proctocolectomy for ulcerative colitis: A twenty years experience
41. P361 Adalimumab in the treatment of perianal Crohn's disease: Long-term results in a single tertiary center
42. P230 Adalimumab in active ulcerative colitis: A “real-life” observational study
43. P375 Efficacy, safety, impact on natural history of long-term treatment with thiopurines in Crohn's disease patients. A single center experience
44. P380 Oral beclomethasone dipropionate in the treatment of chronic refractory pouchitis
45. Ovarian surgery for bilateral endometriomas influences age at menopause
46. Local Injection of Adalimumab for Perianal Crohnʼs Disease: Better Than Infliximab?
47. P161 - Newly diagnosed neoplasia in a cohort of Crohn's disease patients treated or untreated with infliximab followed up in the long term: a multicenter matched-pair study
48. P155 - Efficacy of enemas containing combination of mesalazine and methyl-prednisolone in active distal refractory ulcerative colitis
49. P184 - Adalimumab in the treatment of active luminal and perianal Crohn's disease: a single center experience in 100 patients
50. Which therapies are advisable in pouchitis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.